Phase 1 proof-of-concept study of CLY-124 in Sickle Cell Disease expected in Q4 2026In vivo preclinical data assessing new compounds vs. standard of care in gold-standard, translatable myelofibrosis ...
Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for ...
FREDERICK, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a ...
The Takeout on MSN
12 Surprising Things You Didn't Know About The Michelin Rating System
The Michelin Guide has the power to change the trajectory of a restaurant, but there's a lot of misinformation out there ...
See, despite the name, the Tribute isn’t just for show - the modifications are serving a purpose as well. Or, to put it in ...
Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; ...
Chiplets enable scalability but dramatically raise interconnect complexity and risk. Silicon-proven NoC technology is the key ...
Nandan Nilekani built Aadhaar, India’s vast digital biometric identity system. Now he wants to Aadhaarize the world.
The Pioneer on MSNOpinion
A regulator in turbulence: How the DGCA lost its way
The glory years of the 1970s and 1980s, when Air Marshals such as Jafar Zaheer and Air Vice Marshal C.K. Shantaram Raje—both ...
Destination Charged on MSN
Volkswagen brings back more physical buttons in redesigned ID. interiors
Volkswagen is introducing a redesigned cockpit concept that will roll out across its electric ID. lineup, beginning with the ...
Once-weekly TransCon® CNP and TransCon® hGH combination therapy showed durable growth without compromising safety or ...
The Growing Demand for ACCA in India and How Students Can Prepare Effectively - Indias demand for ACCA literally skyrocketed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback